Anti-CD20 rechallenge with ofatumumab in relapsed/refractory splenic marginal zone lymphoma: the MORE trial.Lydia Scarfò,Silvia Ferrari,Anna Maria Frustaci,Monica Tani, Alessia Bari,Eloise Scarano,Maria Colia,Pamela Ranghetti,Piera Angelillo, Paola Ronchi,Maurilio Ponzoni,Andrés J M Ferreri,Paolo GhiaBlood advances(2022)引用 0|浏览24暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要